Could your gait and blood predict Alzheimer's? new study aims to find out

NCT ID NCT07286812

Not yet recruiting Diagnosis Sponsor: First Hospital of China Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test if combining digital technology (analyzing how people walk, their facial expressions, and speech) with blood markers can better screen for early Alzheimer's disease in community adults aged 50 and older. The goal is to create a more efficient screening method than traditional questionnaires. Researchers will follow 1,000 participants over time to see if these tools can accurately identify those with early cognitive problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simpler, more accurate way to catch Alzheimer's early, allowing for earlier treatment.
What could go wrong: This is an early-stage study that hasn't started recruiting yet. The digital and blood tests may not prove accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Locations

The First Affiliated Hospital of China Medical University

Shenyang, Liaoning, 110001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.